Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Intel
INTC
|
$661M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$484M |
| 3 |
Amazon
AMZN
|
$482M |
| 4 |
Netflix
NFLX
|
$345M |
| 5 |
Pfizer
PFE
|
$314M |
Top Sells
| 1 |
Apple
AAPL
|
$900M |
| 2 |
Microsoft
MSFT
|
$393M |
| 3 |
UnitedHealth
UNH
|
$388M |
| 4 |
Merck
MRK
|
$272M |
| 5 |
Bank of America
BAC
|
$265M |
Sector Composition
| 1 | Technology | 22.26% |
| 2 | Healthcare | 14.77% |
| 3 | Financials | 12.79% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Communication Services | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Zoetis
ZTS
$67.4B
| $813M | 0.4% |
6,907,065
-858,419
| -11% | -$101M |
|
52
Fidelity National Information Services
FIS
$35.6B
| $790M | 0.38% |
6,495,919
-1,312,393
| -17% | -$160M |
|
53
American Express
AXP
$227B
| $786M | 0.38% |
9,182,610
+1,212,685
| +15% | +$104M |
|
54
Eli Lilly
LLY
$660B
| $784M | 0.38% |
5,654,616
+1,533,024
| +37% | +$213M |
|
55
Accenture
ACN
$158B
| $781M | 0.38% |
4,784,408
-267,584
| -5% | -$43.7M |
|
56
Abbott
ABT
$229B
| $765M | 0.37% |
9,697,316
-1,280,522
| -12% | -$101M |
|
57
Tesla
TSLA
$1.1T
| $762M | 0.37% |
1,454,953
-111,591
| -7% | -$58.5M |
|
58
ServiceNow
NOW
$189B
| $760M | 0.37% |
2,652,155
-188,657
| -7% | -$54.1M |
|
59
Amgen
AMGN
$153B
| $757M | 0.37% |
3,735,565
-465,451
| -11% | -$94.4M |
|
60
Equinix
EQIX
$74.9B
| $757M | 0.37% |
1,211,869
+206,455
| +21% | +$129M |
|
61
Mondelez International
MDLZ
$79.2B
| $741M | 0.36% |
14,797,738
-628,445
| -4% | -$31.5M |
|
62
Citigroup
C
$174B
| $725M | 0.35% |
17,212,859
-2,426,533
| -12% | -$102M |
|
63
Cigna
CI
$79.9B
| $718M | 0.35% |
4,055,155
+494,330
| +14% | +$87.6M |
|
64
Broadcom
AVGO
$1.43T
| $717M | 0.35% |
3,023,288
+518,279
| +21% | +$123M |
|
65
Lowe's Companies
LOW
$146B
| $703M | 0.34% |
8,170,002
+1,966,342
| +32% | +$169M |
|
66
Applied Materials
AMAT
$125B
| $686M | 0.33% |
14,977,988
+1,269,297
| +9% | +$58.2M |
|
67
Exxon Mobil
XOM
$478B
| $684M | 0.33% |
18,007,588
-1,338,643
| -7% | -$50.8M |
|
68
Boston Scientific
BSX
$159B
| $670M | 0.33% |
20,542,040
+7,914,016
| +63% | +$258M |
|
69
Vertex Pharmaceuticals
VRTX
$102B
| $655M | 0.32% |
2,751,663
+238,591
| +9% | +$56.8M |
|
70
Baxter International
BAX
$12.2B
| $650M | 0.32% |
8,011,729
+842,305
| +12% | +$68.4M |
|
71
Medtronic
MDT
$119B
| $632M | 0.31% |
7,005,704
+202,760
| +3% | +$18.3M |
|
72
CVS Health
CVS
$93.2B
| $631M | 0.31% |
10,637,398
+9,670
| +0.1% | +$574K |
|
73
L3Harris
LHX
$51.3B
| $625M | 0.3% |
3,471,357
+430,984
| +14% | +$77.6M |
|
74
Morgan Stanley
MS
$238B
| $611M | 0.3% |
17,972,662
+1,705,764
| +10% | +$58M |
|
75
Illumina
ILMN
$15.4B
| $595M | 0.29% |
2,177,806
-290,287
| -12% | -$79.3M |
|